Literature DB >> 9465357

Family physicians' utilization of a brief smoking cessation program following reinforcement contact after training: a randomized trial.

R Richmond1, C Mendelsohn, L Kehoe.   

Abstract

BACKGROUND: Previous studies have examined methods of delivery of brief interventions and reinforcement contact and their effects on physicians' utilization of smoking cessation interventions. In this study the objectives were: (1) to determine the ongoing utilization by family physicians of a brief smoking cessation intervention 6 months after a training workshop and (2) to examine the effect of reinforcement contact on physician utilization. A supplementary aim was to assess point prevalence abstinence among patients identified as ready to quit smoking.
METHODS: This was a randomized controlled trial of family physicians (98 in the Contact and 100 in the Noncontact group). Training was conducted in a 2-hr workshop. Doctors in the Contact group received three brief telephone calls at 2 weeks, 2 months, and 4 months after training. Main outcome measures were: (1) utilization, determined by responses to a mailed questionnaire about use of the program, and (2) the number of booklets distributed by full-time doctors, collected by practice secretaries or research assistant.
RESULTS: At 6 months 88% of physicians (93% of the Contact group and 84% of the Noncontact group, P = 0.06) were current users of the smoking cessation intervention. Full-time physicians in the Contact group distributed significantly more booklets (40.1) over 6 months than those in the Noncontact group (32.8) (P < 0.05). Twenty-one percent of patients reported not smoking at follow-up at an average of 9.9 months after intervention.
CONCLUSIONS: Most doctors continued to use the program 6 months after training and reinforcement contact encouraged greater recruitment of patients.

Entities:  

Mesh:

Year:  1998        PMID: 9465357     DOI: 10.1006/pmed.1997.0240

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

1.  Labeling smokers' charts with a "smoker" sticker: results of a randomized controlled trial among private practitioners.

Authors:  J F Etter; J C Rielle; T V Perneger
Journal:  J Gen Intern Med       Date:  2000-06       Impact factor: 5.128

2.  Cost-effectiveness analysis of smoking-cessation counseling training for physicians and pharmacists.

Authors:  Scott B Cantor; Ashish A Deshmukh; Nancy Stancic Luca; Graciela M Nogueras-González; Tanya Rajan; Alexander V Prokhorov
Journal:  Addict Behav       Date:  2015-01-14       Impact factor: 3.913

3.  From Good to Great: The Role of Performance Coaching in Enhancing Tobacco-Dependence Treatment Rates.

Authors:  Sophia Papadakis; Adam G Cole; Robert D Reid; Roxane Assi; Marie Gharib; Heather E Tulloch; Kerri-Anne Mullen; George Wells; Andrew L Pipe
Journal:  Ann Fam Med       Date:  2018-11       Impact factor: 5.166

4.  Nutrition in primary care: current practices, attitudes, and barriers.

Authors:  Kathryn Wynn; Jacqueline D Trudeau; Kristen Taunton; Margot Gowans; Ian Scott
Journal:  Can Fam Physician       Date:  2010-03       Impact factor: 3.275

5.  Engaging physicians and pharmacists in providing smoking cessation counseling.

Authors:  Alexander V Prokhorov; Karen Suchanek Hudmon; Salma Marani; Lewis Foxhall; Kentya H Ford; Nancy Stancic Luca; David W Wetter; Scott B Cantor; Frank Vitale; Ellen R Gritz
Journal:  Arch Intern Med       Date:  2010-10-11

Review 6.  Strategies to improve smoking cessation rates in primary care.

Authors:  Nicola Lindson; Gillian Pritchard; Bosun Hong; Thomas R Fanshawe; Andrew Pipe; Sophia Papadakis
Journal:  Cochrane Database Syst Rev       Date:  2021-09-06

7.  Acceptability and effectiveness of opportunistic referral of smokers to telephone cessation advice from a nurse: a randomised trial in Australian general practice.

Authors:  Jane M Young; Seham Girgis; Tracey A Bruce; Melissa Hobbs; Jeanette E Ward
Journal:  BMC Fam Pract       Date:  2008-02-28       Impact factor: 2.497

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.